Literature DB >> 32128568

Vascular α1-Adrenergic Receptor Responsiveness in Masked Hypertension.

Yuichiro Yano1, Anthony J Viera1, Alan L Hinderliter2, Lana L Watkins3, James A Blumenthal3, Kristy S Johnson3, LaBarron K Hill3, Andrew Sherwood3.   

Abstract

BACKGROUND: Masked hypertension (nonhypertensive in the clinic setting but hypertensive outside the clinic during wakefulness) is characterized by increased blood pressure in response to physical and emotional stressors that activate the sympathetic nervous system (SNS). However, no studies have assessed vascular reactivity to a pharmacological SNS challenge in individuals with masked hypertension.
METHODS: We analyzed data from 161 adults aged 25 to 45 years (mean ± standard deviation age 33 ± 6 years; 48% were African American and 43% were female). Participants completed ambulatory blood pressure monitoring, and a standardized α 1-adrenergic agonist phenylephrine test that determines the dose of phenylephrine required to increase a participant's mean arterial pressure by 25 mm Hg (PD25).
RESULTS: Twenty-one participants were considered to have masked hypertension (clinic systolic blood pressure (SBP) <140 and diastolic blood pressure (DBP) <90 mm Hg but awake SBP ≥135 or DBP ≥85 mm Hg), 28 had sustained hypertension (clinic SBP ≥140 or DBP ≥90 mm Hg and awake SBP ≥135 or DBP ≥85 mm Hg), and 106 had sustained normotension (clinic SBP <140 and DBP <90 mm Hg and awake SBP <135 and DBP <85 mm Hg). After multivariable adjustment, the mean (±SE) PD25 was less in participants with masked hypertension compared with their counterparts with sustained normotension (222.1 ± 33.2 vs. 328.7 ± 15.0; P = 0.012), but similar to that observed in subjects with sustained hypertension (254.8 ± 31.0; P =0.12).
CONCLUSIONS: Among young and middle-aged adults, masked hypertension is associated with increased vascular reactivity to a SNS challenge, which may contribute to elevated awake BPs as well as to increased cardiovascular disease risk. © American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  adrenergic receptors; blood pressure; hypertension; masked hypertension; sympathetic nervous system

Mesh:

Substances:

Year:  2020        PMID: 32128568      PMCID: PMC7402222          DOI: 10.1093/ajh/hpaa032

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   3.080


  33 in total

Review 1.  Alpha1-adrenergic receptors: new insights and directions.

Authors:  M T Piascik; D M Perez
Journal:  J Pharmacol Exp Ther       Date:  2001-08       Impact factor: 4.030

2.  Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing.

Authors:  G Parati; R Casadei; A Groppelli; M Di Rienzo; G Mancia
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

3.  Impact of Racial Discrimination and Hostility on Adrenergic Receptor Responsiveness in African American Adults.

Authors:  LaBarron K Hill; Andrew Sherwood; Maya McNeilly; Norman B Anderson; James A Blumenthal; Alan L Hinderliter
Journal:  Psychosom Med       Date:  2018 Feb/Mar       Impact factor: 4.312

4.  Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study.

Authors:  Kageumi Takeno; Tomoya Mita; Shiho Nakayama; Hiromasa Goto; Koji Komiya; Hiroko Abe; Fuki Ikeda; Tomoaki Shimizu; Akio Kanazawa; Takahisa Hirose; Ryuzo Kawamori; Hirotaka Watada
Journal:  Am J Hypertens       Date:  2011-11-17       Impact factor: 2.689

5.  Orthostatic hypertension due to vascular adrenergic hypersensitivity.

Authors:  N L Benowitz; S Zevin; S Carlsen; J Wright; M Schambelan; M Cheitlin
Journal:  Hypertension       Date:  1996-07       Impact factor: 10.190

6.  Race and sex differences in cardiovascular α-adrenergic and β-adrenergic receptor responsiveness in men and women with high blood pressure.

Authors:  Andrew Sherwood; LaBarron K Hill; James A Blumenthal; Kristy S Johnson; Alan L Hinderliter
Journal:  J Hypertens       Date:  2017-05       Impact factor: 4.844

Review 7.  Timing of blood pressure measurement related to caffeine consumption.

Authors:  Jane R Mort; Heather R Kruse
Journal:  Ann Pharmacother       Date:  2007-12-19       Impact factor: 3.154

8.  Ethnic differences in left ventricular structure: relations to hemodynamics and diurnal blood pressure variation.

Authors:  Alan L Hinderliter; James A Blumenthal; Robert Waugh; Mohan Chilukuri; Andrew Sherwood
Journal:  Am J Hypertens       Date:  2004-01       Impact factor: 2.689

9.  Neurogenic abnormalities in masked hypertension.

Authors:  Guido Grassi; Gino Seravalle; Fosca Quarti Trevano; Raffaella Dell'oro; Gianbattista Bolla; Cesare Cuspidi; Francesca Arenare; Giuseppe Mancia
Journal:  Hypertension       Date:  2007-07-09       Impact factor: 10.190

10.  Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population.

Authors:  Kei Asayama; Lutgarde Thijs; Yan Li; Yu-Mei Gu; Azusa Hara; Yan-Ping Liu; Zhenyu Zhang; Fang-Fei Wei; Inés Lujambio; Luis J Mena; José Boggia; Tine W Hansen; Kristina Björklund-Bodegård; Kyoko Nomura; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Katarzyna Stolarz-Skrzypek; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Leonella Luzardo; Kalina Kawecka-Jaszcz; Edgardo Sandoya; Jan Filipovský; Gladys E Maestre; Jiguang Wang; Yutaka Imai; Stanley S Franklin; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2014-08-18       Impact factor: 10.190

View more
  1 in total

1.  Clinical Study on the Treatment of Female Stress Urinary Incontinence With Modified Buzhong Yiqi Decoction.

Authors:  Feifei Zhou; Chen Chen; Jiani Shi; Qianru Zhou; Lijun Jin; Xiaofang Ma
Journal:  Front Surg       Date:  2022-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.